What About Biosimilars in Dermatology? Q&A With Steven R. Feldman, MD
Medscape Dermatology asked Steven R. Feldman, MD, PhD, professor of dermatology at Wake Forest University School of Medicine, Winston-Salem, North Carolina, to share his expertise on the impact biosimilar versions of FDA-approved biologics are having in dermatology. How do you characterize the availability of biosimilars for treating psoriasis, atopic dermatitis, and other skin diseases? Can you provide […]
What About Biosimilars in Dermatology? Q&A With Steven R. Feldman, MD Read More »
